• Turnover for the first time above €3 million
• Significant reduction in consolidated net loss to -€8.7 million compared to -€12 million in 2022
• Gross cash amounting to €11.7 million as of 12/31/23 vs. €8.8 million a year earlier
• Successful marketing of the first tonnes of Isonaturane™ 12 to several clients including L’Oréal
• Obtaining ASTM certification for the production of sustainable aviation fuels
• Continuing collaboration with Shell for the development of low-carbon road fuels
• Obtaining major public funding, for a total amount of €21 million, in particular for the construction of the factory dedicated to cosmetics
• Recruitment of key people, in particular an Industrial Director and a Chief Business Officer
• Progress in the CSR approach: award of the EcoVadis bronze medal and 30% reduction in electricity consumption at the Evry site in two years
Evry, March 6, 2024 – 5:45 p.m.: The Board of Directors of Global Bioenergies held yesterday approved the 2023 annual accounts, which show a significantly reduced loss, at €8.7 million.
Samuel Dubruque, Administrative and Financial Director of Global Bioenergies, comments: “The year 2023 is marked by strong growth in turnover reaching a record level, above €3 million, and by a significant improvement in net income.